Centers for Disease Control and Prevention. Fast Facts on Global Hepatitis B. Available from: https://www.cdc.gov/globalhealth/immunization/diseases/hepatitis-b/data/fast-facts.html. Accessed 22 Aug 2023.

World Health Organization. Combating hepatitis B and C to reach elimination by 2030. Available from: https://www.who.int/publications/i/item/combating-hepatitis-b-and-c-to-reach-elimination-by-2030. Accessed 22 Aug 2023.

Kim SS, Cheong JY, Cho SW. Current nucleos(t)ide analogue therapy for chronic hepatitis B. Gut liver. 2011;5(3):278–87.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399–408.

Article  PubMed  Google Scholar 

World Health Organization. Hepatitis B. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 22 Aug 2023.

Kemp L, Clare KE, Brennan PN, Dillon JF. New horizons in hepatitis B and C in the older adult. Age Ageing. 2019;48(1):32–7.

Article  PubMed  Google Scholar 

Wong GL, Wong VW, Yuen BW, Tse YK, Luk HW, Yip TC, et al. An aging population of chronic hepatitis B with increasing comorbidities: a territory-wide study from 2000 to 2017. Hepatology. 2020;71(2):444–55.

Article  PubMed  Google Scholar 

Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, et al. Advancing age and comorbidity in a US insured population-based cohort of patients with chronic hepatitis B. Hepatology. 2019;69(3):959–73.

Article  PubMed  Google Scholar 

Xie J, Wang X, Pan D, Liu J, Li J, Gu J. Ageing and non-liver comorbidities in population with chronic hepatitis B infection in the western pacific region from 1990 to 2019. Front Physiol. 2023;14:1176113.

Article  PubMed  PubMed Central  Google Scholar 

Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, et al. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015;62(5):1364–74.

Article  PubMed  CAS  Google Scholar 

Raddatz D, Ramadori G. Carbohydrate metabolism and the liver: actual aspects from physiology and disease. Z Gastroenterol. 2007;45(1):51–62.

Article  PubMed  CAS  Google Scholar 

Tappy L, Minehira K. New data and new concepts on the role of the liver in glucose homeostasis. Curr Opin Clin Nutr Metab Care. 2001;4(4):273–7.

Article  PubMed  CAS  Google Scholar 

Cai C, Zeng J, Wu H, Shi R, Wei M, Gao Y, et al. Association between hepatitis B virus infection and diabetes mellitus: a meta-analysis. Exp Ther Med. 2015;10(2):693–8.

Article  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control and Prevention. People with diabetes and hepatitis B. Available from: https://www.cdc.gov/hepatitis/populations/diabetes.htm. Accessed 22 Aug 2023.

Sawyer MH, Hoerger TJ. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(50):1709–11.

Google Scholar 

McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45-55.

Article  PubMed  CAS  Google Scholar 

Younossi Z, Kochems K, de Ridder M, Curran D, Bunge EM, de Moerlooze L. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Hum Vaccin Immunother. 2017;13(11):2695–706.

Article  PubMed  PubMed Central  Google Scholar 

Di Bisceglie AM. What every hepatologist should know about endocrinology: obesity, diabetes, and liver disease. Gastroenterology. 2004;126(2):604–6.

Article  PubMed  Google Scholar 

Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med. 2017;5(13):270.

Article  PubMed  PubMed Central  Google Scholar 

Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001;34(4 Pt 1):738–44.

Article  PubMed  CAS  Google Scholar 

Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clin Infect Dis. 2013;57(12):1695–702.

Article  PubMed  Google Scholar 

Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol. 2015;30(3):591–9.

Article  PubMed  CAS  Google Scholar 

Campbell C, Wang T, McNaughton AL, Barnes E, Matthews PC. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis. J Viral Hepat. 2021;28(3):493–507.

Article  PubMed  CAS  Google Scholar 

Mrzljak A, Cigrovski Berkovic M, Giovanardi F, Lai Q. The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis. Croat Med J. 2022;63(2):176–86.

Article  PubMed  PubMed Central  CAS  Google Scholar 

World Health Organization. Breaking the hold of viral hepatitis. Available from: https://www.who.int/china/activities/breaking-the-hold-of-viral-hepatitis/breaking-the-hold-of-viral-hepatitis. Accessed 22 Aug 2023.

Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–506.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Wu J, Ding C, Xu K, Yang S, Li L. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study. Virol J. 2020;17(1):132.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Z, Li M, Hutton DW, Wagner AL, Yao Y, Zhu W, et al. Impact of the national hepatitis B immunization program in China: a modeling study. Infect Dis Poverty. 2022;11(1):106.

Article  PubMed  PubMed Central  Google Scholar 

Jing W, Liu J, Wu Y, Ma Q, Liu M. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: a decision-analytic Markov model. EClinicalMedicine. 2020;19:100264.

Article  PubMed  PubMed Central  Google Scholar 

Department of Population and Employment Statistics National Bureau of Statistics of China: China Population and Employment Statistics Yearbook. China Statistics Press, Beijing, 2022.

Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease. China Bull World Health Organ. 2019;97(3):230–8.

Article  PubMed  Google Scholar 

World Health Organization. Hepatitis in China. Available from: https://www.who.int/china/health-topics/hepatitis. Accessed 22 Aug 2023.

Wang X, Du Z, Wang Y, Wang J, Huang S, Wang Y, et al. Impact and cost-effectiveness of biomedical interventions on adult hepatitis B elimination in China: a mathematical modelling study. J Epidemiol Glob Health. 2023;13:517–27.

Article  PubMed  PubMed Central  Google Scholar 

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–7.

Article  PubMed  Google Scholar 

Lu FM, Li T, Liu S, Zhuang H. Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat. 2010;17(Suppl 1):4–9.

Article  PubMed  Google Scholar 

Shan S, Cui F, Jia J. How to control highly endemic hepatitis B in Asia. Liver Int. 2018;38(Suppl 1):122–5.

Article  PubMed  Google Scholar 

Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. Progress toward hepatitis B control and elimination of mother-to-child transmission of hepatitis B virus—Western Pacific Region, 2005–2017. MMWR Morb Mortal Wkly Rep. 2019;68(8):195–200.

Article  PubMed  PubMed Central  Google Scholar 

Zu J, Zhuang G, Liang P, Cui F, Wang F, Zheng H, et al. Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model. Sci Rep. 2017;7(1):2912.

Article  PubMed  PubMed Central  Google Scholar 

Moini M, Fung S. HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure. Viruses. 2022;14(4):657.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450–5.

Article  PubMed  CAS  Google Scholar 

Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183–92.

Article  PubMed  CAS  Google Scholar 

Iss A, Ab C, Js A. Changes in plasma free fatty acids associated with type-2 diabetes. Nutrients. 2019;11(9):2022.

Article